Which Patients With Rectal Cancer Do Not Need Radiotherapy?

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Standard treatment for locally advanced rectal cancer includes preoperative (chemo)radiotherapy, surgery, and adjuvant chemotherapy.
• Advances have decreased local recurrence rates to below 10%.

Purpose of the Study:

• To evaluate the current treatment paradigm for locally advanced rectal cancer.
• To address the challenge of distant metastases, which affect over 25% of patients.
• To explore the potential for selective use of radiotherapy due to decreased local recurrence and treatment toxicity.

Main Methods:

• Review of current treatment guidelines and outcomes for locally advanced rectal cancer.
• Analysis of factors contributing to local recurrence and distant metastases.
• Assessment of treatment-induced toxicity and its impact on treatment selection.

Main Results:

• Local recurrence rates have significantly decreased due to improved surgical and oncological therapies.
• Distant metastases remain a primary challenge, occurring in over 25% of patients.
• Increased awareness of treatment toxicity prompts re-evaluation of standard protocols.

Conclusions:

• The effectiveness of standard preoperative (chemo)radiotherapy in reducing local recurrence is established.
• The persistent high rate of distant metastases necessitates a shift towards systemic therapies.
• A more selective application of radiotherapy may be warranted to mitigate toxicity while addressing distant disease.